[go: up one dir, main page]

WO2013109216A3 - Préparation de formulations en poudre sèche comprenant du tiotropium - Google Patents

Préparation de formulations en poudre sèche comprenant du tiotropium Download PDF

Info

Publication number
WO2013109216A3
WO2013109216A3 PCT/TR2013/000028 TR2013000028W WO2013109216A3 WO 2013109216 A3 WO2013109216 A3 WO 2013109216A3 TR 2013000028 W TR2013000028 W TR 2013000028W WO 2013109216 A3 WO2013109216 A3 WO 2013109216A3
Authority
WO
WIPO (PCT)
Prior art keywords
tiotropium
preparation
dry powder
powder formulations
copd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2013/000028
Other languages
English (en)
Other versions
WO2013109216A2 (fr
Inventor
Mahmut Bilgic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP13738848.4A priority Critical patent/EP2804591A2/fr
Publication of WO2013109216A2 publication Critical patent/WO2013109216A2/fr
Publication of WO2013109216A3 publication Critical patent/WO2013109216A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne un procédé de préparation de formulations pharmaceutiques en poudre sèche comprenant du tiotropium ou ses dérivés pharmaceutiquement acceptables. Ces formulations sont utilisables dans le traitement symptomatique et/ou prophylactique de maladies des voies respiratoires, notamment l'asthme et la broncho-pneumopathie chronique obstructive.
PCT/TR2013/000028 2012-01-16 2013-01-16 Préparation de formulations en poudre sèche comprenant du tiotropium Ceased WO2013109216A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13738848.4A EP2804591A2 (fr) 2012-01-16 2013-01-16 Préparation de formulations en poudre sèche comprenant du tiotropium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2012/00492 2012-01-16
TR201200492 2012-01-16

Publications (2)

Publication Number Publication Date
WO2013109216A2 WO2013109216A2 (fr) 2013-07-25
WO2013109216A3 true WO2013109216A3 (fr) 2014-04-17

Family

ID=48237229

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/TR2013/000028 Ceased WO2013109216A2 (fr) 2012-01-16 2013-01-16 Préparation de formulations en poudre sèche comprenant du tiotropium
PCT/TR2013/000025 Ceased WO2013109213A2 (fr) 2012-01-16 2013-01-16 Formulations pharmaceutiques comprenant du tiotropium

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/TR2013/000025 Ceased WO2013109213A2 (fr) 2012-01-16 2013-01-16 Formulations pharmaceutiques comprenant du tiotropium

Country Status (2)

Country Link
EP (1) EP2804591A2 (fr)
WO (2) WO2013109216A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136919A1 (en) * 2002-11-28 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP2172190A1 (fr) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Particules inhalables comprenant du tiotropium
WO2011093820A2 (fr) * 2010-01-28 2011-08-04 Mahmut Bilgic Composition pharmaceutique combinée comprenant du tiotropium
WO2011093819A2 (fr) * 2010-01-28 2011-08-04 Mahmut Bilgic Nouvelle composition pharmaceutique combinée comprenant du tiotropium
WO2011152804A2 (fr) * 2010-06-03 2011-12-08 Mahmut Bilgic Procédé pour formulations pulvérulentes sèches

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136919A1 (en) * 2002-11-28 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP2172190A1 (fr) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Particules inhalables comprenant du tiotropium
WO2011093820A2 (fr) * 2010-01-28 2011-08-04 Mahmut Bilgic Composition pharmaceutique combinée comprenant du tiotropium
WO2011093819A2 (fr) * 2010-01-28 2011-08-04 Mahmut Bilgic Nouvelle composition pharmaceutique combinée comprenant du tiotropium
WO2011152804A2 (fr) * 2010-06-03 2011-12-08 Mahmut Bilgic Procédé pour formulations pulvérulentes sèches

Also Published As

Publication number Publication date
WO2013109213A2 (fr) 2013-07-25
WO2013109213A3 (fr) 2013-09-06
EP2804591A2 (fr) 2014-11-26
WO2013109216A2 (fr) 2013-07-25

Similar Documents

Publication Publication Date Title
WO2012016889A3 (fr) Formulation de poudre sèche comprenant un inhibiteur de phosphodiestérase
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
IL230874A (en) History of dihydroquinoline-2-on-egg scallops, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
WO2014064410A3 (fr) Composition pharmaceutique
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
IL222120A (en) Annals (indole-1-yl) -carbonylalkyl, process for preparation, pharmaceutical preparations containing them and their use in the preparation of cancer drugs
HK1206670A1 (en) Method and apparatus
WO2014016548A3 (fr) Composition pharmaceutique
TR201000681A2 (tr) İnhalasyon yoluyla alınan kuru toz formülasyonları.
PH12016500043A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-andrenergic for administration by inhalation
ZA201401568B (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
WO2011152804A3 (fr) Procédé pour formulations pulvérulentes sèches
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
IL213983A (en) Derivatives of pyridazinone that are converted into heteroaryl, their process, their pharmaceutical preparations and their use in the preparation of drugs
TR201000623A2 (tr) Yeni tiotropyum kombinasyonu.
IL213671A (en) Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines
WO2011093818A3 (fr) Compositions pharmaceutiques comprenant du salmétérol et du fluticasone
WO2011093815A3 (fr) Compositions pharmaceutiques comprenant du formotérol et du mométasone
WO2014167579A3 (fr) Compositions pharmaceutiques stables de tadalafil
WO2015049519A3 (fr) Procédé et appareil
WO2013153349A3 (fr) Composition pharmaceutique
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
WO2013109216A3 (fr) Préparation de formulations en poudre sèche comprenant du tiotropium
WO2011093811A3 (fr) Préparations pharmaceutiques comprenant du formotérol et du fluticasone

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2013738848

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13738848

Country of ref document: EP

Kind code of ref document: A2